IRMD IRadimed Corporation
USHealthcareAs of 2026-07-10 16:00
Why IRMD matters now
IRadimed Corporation (IRMD) is a US stock in Healthcare. The latest InvestLog snapshot shows $97.20 with -0.86% on the session and $1.24B in market capitalization; recent performance reads 1-month +5.54% and YTD -5.22%.
The latest financial table shown here is Q1 2026, with revenue of $22.0M, net income of $5.8M, and EPS of $0.45. Investors can compare that operating picture with valuation signals such as P/E 53.11 and FCF yield 2.0%.
The latest indexable market news headline is "IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It" from Fool - Investing News.
Additional event context on this page matters because analyst consensus is Buy with a median target of $120.00; recent insider activity includes Scharen-Guivel Hilda Frederique filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
53.11
PEG
3.15
P/B
11.96
P/S
13.66
EV/EBITDA
34.82
DCF Value
$50.92
FCF Yield
2.0%
Div Yield
1.3%
Margins & Returns
Gross Margin
76.8%
Operating Margin
32.4%
Net Margin
27.4%
ROE
24.5%
ROA
20.6%
ROIC
21.4%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $22.0M | $5.8M | $0.45 |
| Q4 2025 | $22.7M | $6.4M | $0.50 |
| FY 2025 | $83.8M | $22.5M | $1.75 |
| Q3 2025 | $21.2M | $5.6M | $0.43 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$120.00
Target (Median)
$120.00
Target Range
$120.00 - $120.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.92
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.